6 A small (n=36) 12-week, placebo-controlled pilot study of the IL-6 receptor inhibitor, tocilizumab, in moderate-to-severe CD ... the OLE trial as responders and who had been on active drug in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback